InvestorsHub Logo
Followers 829
Posts 119621
Boards Moderated 14
Alias Born 09/05/2002

Re: DaveAu post# 1676

Tuesday, 08/07/2018 3:12:21 PM

Tuesday, August 07, 2018 3:12:21 PM

Post# of 2959
Other PBMs haven't yet released their planned 2019 formularies, as far as I know.

ABBV has said all along that Mavyret's focus in the US market is on the government segment of the market, where PBMs play no role. So, even if CVS or another large PBM were to shun Mavyret in 2019, the damage wouldn't be that bad.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENTA News